← Open Payments lookup

SEAN SMITHSON: Open Payments

NPI 1467133348 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$247 in 12 payments from 9 companies in 2025. Trend: 2023 $17 · 2024 $129 · 2025 $247

Food & beverage: $247
CompanyPaymentsAmount
Novo Nordisk Inc3$67
Sumitomo Pharma America, Inc.2$40
Exact Sciences Corporation1$30
ABBVIE INC.1$26
Lilly USA, LLC1$21
AstraZeneca Pharmaceuticals LP1$20
Janssen Pharmaceuticals, Inc1$16
Takeda Pharmaceuticals U.S.A., Inc.1$14
Phathom Pharmaceuticals, Inc.1$12

Products named: GEMTESA, Cologuard Collection Kit, Rybelsus, UBRELVY, MOUNJARO, Wegovy, FARXIGA, Ozempic.

Industry payments across MD — which companies pay providers there.